Cat.#: ACPP-1821
| Despition | NT 4 Human Recombinant |
| SIZE | 2 µg |
| Purity | > 97.0% (SDS-PAGE) |
| Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1428 | Mouse LGALS7 Protein (AC1428) | 5 µg | inquiry |
| ACPP-1574 | Human NDUFS4 Protein (AC1574) | 5 µg | inquiry |
| ACPP-1631 | Human IMPDH1 Protein (AC1631) | 2 µg | inquiry |
| ACPP-1531 | Human CHMP2B Protein (AC1531) | 5 µg | inquiry |
| ACPP-1657 | Human CRCP Protein (AC1657) | 5 µg | inquiry |
| ACPP-1772 | Human CALB2 Protein (AC1772) | 5 µg | inquiry |
| ACPP-1173 | Recombinant Human alpha Synuclein Protein (AC1173) | 50 µl | inquiry |
| ACPP-1336 | Estrogen Receptor alpha Blocking Peptide (AC1336) | 250 µg | inquiry |
| ACPP-1731 | Human DNAJC19 Protein (AC1731) | 2 µg | inquiry |
| ACPP-1826 | Human CRYGN Protein (AC1826) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.